abnormal xenobiotic pharmacokinetics_Abcc2<tm1Ahs>/Abcc2<tm1Ahs>

http://metadb.riken.jp/0008875I129P2OlaHsdFVBAbcc2tm1AhsAbcc2tm1AhsAbcc2tm1Ahs

abnormal xenobiotic pharmacokinetics_Abcc2<tm1Ahs>/Abcc2<tm1Ahs>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• ATP-binding cassette, sub-family C (CFTR/MRP), member 2
  http://metadb.riken.jp/db/mgi_rdf/MGI:1352447

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Abcc2<tm1Ahs>/Abcc2<tm1Ahs>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Abcc2<tm1Ahs>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: 129P2/OlaHsd * FVB

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• abnormal xenobiotic pharmacokinetics
  http://purl.obolibrary.org/obo/MP_0008875

文献

http://purl.org/net/cito/citesAsAuthority

• M L H. Vlaming, et.al., Carcinogen and anticancer drug transport by Mrp2 in vivo: studies using Mrp2 (Abcc2) knockout mice., The Journal of pharmacology and experimental therapeutics, 2006, 318
  http://rdf.ncbi.nlm.nih.gov/pubmed/16611851